Epilepsy medication risks in pregnancy reviewed | News | News and Events

Epilepsy medication risks in pregnancy reviewed

A review of anti-seizure medication (ASM) use in pregnancy has been published, showing that some ASMs are safer to use than others.

Some ASMs can affect the development of a baby during pregnancy. This might be a factor in deciding which ASM is right for women and girls, even at a young age.

The Medicines and Healthcare products Regulatory Agency (MHRA) published the review, alongside a patient leaflet, to help individuals and healthcare professionals understand the evidence available.

Women and girls with epilepsy should have their medication regularly reviewed by their epilepsy specialist.

Read the patient leaflet 

Read the medication review

Share with friends

Cyber EssentialsFundraising RegulatorYoung Epilepsy is the operating name of The National Centre for Young People with Epilepsy Charitable Trust.
Registered Charity number 311877 (England and Wales)

We use cookies to improve our website and your experience when using it. Cookies used for the essential operation of the site have already been set. To find out more about the cookies we use and how to delete them, see our Privacy Policy.

I accept cookies from this site
EU Cookie Directive plugin by www.channeldigital.co.uk